Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Institute for Prevention Research and Epidemiology - BIPS is one of the oldest epidemiological research institutes in Germany. With more than 200 employees, BIPS is focused on researching and developing
-
Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH | Bremen, Bremen | Germany | 11 days ago
200 employees, BIPS is focused on researching and developing preventive measures for non-communicable diseases. We work interdisciplinary to develop scientifically-based approaches to disease prevention
-
and ageing Design and perform molecular studies on iPSC-derived skeletal muscle cells and aged mouse models Independently analyze data and develop innovative experiments Support the preparation
-
Institute for Prevention Research and Epidemiology - BIPS is one of the oldest epidemiological research institutes in Germany. With more than 200 employees, BIPS is focused on researching and developing
-
well as a comprehensive portfolio of training and career development opportunities. Each fellow will be embedded in a co-supervision framework designed to support high-quality mentorship, promote mutual
-
team opportunity to lead the development of a new high-density EEG lab, including MR-compatible source localization setup (64 active electrodes, shielded chamber) access to top-tier research
-
The Leibniz Institute for Solid State and Materials Research Dresden e. V. (IFW Dresden) conducts modern materials research on a scientific basis for the development of new and sustainable materials
-
. Applying online in the DAAD portal (Read notes on applying in the portal >> ) Prepare application documents If necessary, translate documents (unless they are already in German or English). Scan paper
-
available in the further tabs (e.g. “Application requirements”). Programme Description The programme is intended for highly qualified scientists and scholars of all disciplines from selected developing
-
projects on metabolic diseases * Develop and apply machine learning models for biomarker discovery, patient stratification, and prediction of disease trajectories * Collaborate with clinicians